|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/395 | |||
| C07K 16/18 | |||
| C07K 16/28 |
| (11) | Number of the document | 2611464 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11820900.6 |
| Date of filing the European patent application | 2011-09-02 | |
| (97) | Date of publication of the European application | 2013-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/050439 |
| Date | 2011-09-02 |
| (87) | Number | WO 2012/031273 |
| Date | 2012-03-08 |
| (30) | Number | Date | Country code |
| 380181 P | 2010-09-03 | US |
| (72) |
DYLLA, Scott J., US
FOORD, Orit, US
STULL, Robert A., US
ANDERSON, Wade C., US
OHSHIMA, Saiyou, US
|
| (73) |
AbbVie Stemcentrx LLC,
1 North Waukegan Road, North Chicago, IL 60064-6400,
US
|
| (54) | NOVEL MODULATORS AND METHODS OF USE |
| NOVEL MODULATORS AND METHODS OF USE |